Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Intangibles (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Intangibles for 14 consecutive years, with $5.7 million as the latest value for Q4 2025.

  • Quarterly Intangibles rose 1476.6% to $5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, up 1476.6% year-over-year, with the annual reading at $5.7 million for FY2025, 1476.6% up from the prior year.
  • Intangibles for Q4 2025 was $5.7 million at Niagen Bioscience, up from $246000.0 in the prior quarter.
  • The five-year high for Intangibles was $5.7 million in Q4 2025, with the low at $246000.0 in Q3 2025.
  • Average Intangibles over 5 years is $849210.5, with a median of $591000.0 recorded in 2023.
  • Peak annual rise in Intangibles hit 1476.6% in 2025, while the deepest fall reached 38.04% in 2025.
  • Over 5 years, Intangibles stood at $857000.0 in 2021, then dropped by 21.7% to $671000.0 in 2022, then decreased by 23.99% to $510000.0 in 2023, then dropped by 29.61% to $359000.0 in 2024, then surged by 1476.6% to $5.7 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $5.7 million, $246000.0, and $284000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.